Principal Components Analysis of Agitation Outcomes in Alzheimer's disease

BACKGROUND: We developed a composite measure of agitation as a secondary outcome of change over time in the Citalopram for Agitation in Alzheimer's disease study (CitAD). CitAD demonstrated a positive effect of citalopram on agitation on the Neurobehavioral Rating Scale agitation subscale (NBRS...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Psychiatr Res
Prif Awduron: Yesavage, Jerome A., Taylor, Joy L., Friedman, Leah, Rosenberg, Paul B., Lazzeroni, Laura C., Leoutsakos, Jeannie-Marie S., Kinoshita, Lisa M., Perlow, Mark J., Munro, Cynthia A., Devanand, D.P., Drye, Lea T., Mintzer, Jacobo E., Pollock, Bruce G., Porsteinsson, Anton P., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Lyketsos, Constantine G., Noda, Art
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891245/
https://ncbi.nlm.nih.gov/pubmed/27115509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2016.04.004
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg